Professional Documents
Culture Documents
CVS Health Corporation (NYS: CVS)
CVS Health Corporation (NYS: CVS)
Consolidated Yes
Scale Thousands
Cash & cash equivalents 5683000
Short-term investments -
Investments 2373000
Accounts receivable, gross 19936000
Less: allowance for doubtful accounts 319000
Accounts receivable, net 19617000
Inventories 17516000
Deferred income taxes -
Other current assets 5113000
Total current assets 50302000
Long-term investments 17314000
Land 1981000
Buildings & improvements 4068000
Fixtures & equipment 13807000
Leasehold improvements 5611000
Software 3467000
Total property & equipment, gross 28934000
Accumulated depreciation & amortization 16890000
Property & equipment, net 12044000
Operating lease right-of-use assets 20860000
Goodwill 79749000
Intangible assets, net 33121000
Separate accounts assets 4459000
Other assets 4600000
Total assets 222449000
Accounts payable 10492000
Pharmacy claims & discounts payable 13601000
Claims & discounts payable -
Health care costs payable 6879000
Policyholders? funds 2991000
Accrued expenses 12133000
Other insurance liabilities 1830000
Current portion of operating lease liabilities 1596000
Commercial paper -
Short-term debt -
Current portion of long-term debt 3781000
Total current liabilities 53303000
Long-term operating lease liabilities 18926000
Senior notes 66882000
Senior exchange debentures -
Floating rate notes 1277000
Tranche loans -
Capital lease obligations 808000
Other long-term debt 279000
Total long-term debt 69246000
Debt premiums 262000
Debt discounts & deferred financing costs -1028000
Less: short-term debt, commercial paper -
Less: current portion of long-term debt 3781000
Long-term debt 64699000
Deferred income taxes 7294000
Separate accounts liabilities 4459000
Other long-term insurance liabilities 7436000
Other long-term liabilities 2162000
Total liabilities 158279000
Redeemable noncontrolling interest -
Common stock 45972000
Common stock & capital surplus -
Treasury stock, at cost 28235000
Shares held in trust -
Capital surplus -
Retained earnings 45108000
Net unrealized investment gains (losses) 774000
Foreign currency 4000
Gains (losses) cash flow hedges 279000
Pension & other postretirement benefits -38000
Accumulated other comprehensive income (loss) 1019000
Total CVS Health Corporation shareholders' equity 63864000
Noncontrolling interest 306000
Total shareholders' equity 64170000
Consolidated Yes
Scale Thousands
Products 185236000
Premiums 63122000
Services 7407000
Net investment income 1011000
Net revenues 256776000
Cost of revenues -
Gross profit -
Cost of products sold 158719000
Benefit costs 52529000
Goodwill impairments -
Operating expenses 33541000
Operating expenses -
Operating profit (loss) 11987000
Interest expense -
Interest income -
Interest income (expense), net -3035000
Gain (loss) on early extinguishment of debt -79000
Other expense (income) 124000
Other expenses -
Income (loss) before income tax provision 8997000
Current income tax provision - federal 2450000
Current income tax provision - state 565000
Total current income tax provision 3015000
Deferred income tax provision (benefit) - federal -535000
Deferred income tax provision (benefit) - state -114000
Total deferred income tax provision (benefit) -649000
Income tax provision 2366000
Income (loss) from continuing operations 6631000
Loss from discontinued operations, net of tax -
Net income (loss) 6631000
Less: net income (loss) attributable to noncontrolling interest 3000
Net income attributable to CVS Health Corporation 6634000
Less: amounts allocable to participating securities -
Net income to common -
Weighted average shares outstanding - basic 1301000
Weighted average shares outstanding - diluted 1305000
Year end shares outstanding 1302000
Income (loss) per share from continuing operations - basic 5.1
Income (loss) per share from discontinued operations - basic -
Net income (loss) per share - basic 5.1
Income (loss) per share from continuing operations - diluted 5.08
Income (loss) per share from discontinued operations - diluted -
Net income (loss) per share - diluted 5.08
Dividends declared per common share 2
Total operating costs 244789000
Number of full time employees -
Number of part time employees -
Total number of employees 290000
Number of common stockholders 26656
Foreign currency translation adjustments 162000
Consolidated Yes
Scale Thousands
Previous retained earnings 40911000
Adoption of new accounting standards 178000
Changes in inventory accounting principles -
Common stock dividends 2615000
Retained earnings 45108000
Consolidated Yes
Scale Thousands
Cash receipts from customers 248393000
Cash paid for inventory & prescriptions dispensed by retail ne -149655000
Insurance benefits paid -52242000
Cash paid to other suppliers & employees -28932000
Interest & investment income received 955000
Interest received -
Interest paid -2954000
Income taxes paid -2717000
Net cash flows from operating activities 12848000
Purchases of property & equipment -2457000
Proceeds from sale-leaseback transactions 5000
Purchases of investments -7534000
Proceeds from sale of property & equipment & other assets -
Acquisitions (net of cash acquired) & other investments -
Acquisitions (net of cash acquired) -444000
Proceeds from sale of subsidiary & other assets -
Purchase of available-for-sale investments -
Maturity of available-for-sale investments -
Proceeds from sales & maturities of investments 7049000
Other investing activities 42000
Net cash flows from investing activities -3339000
Increase (decrease) in short-term debt -720000
Proceeds from issuance of long-term debt 3736000
Repayments of long-term debt -8336000
Purchase of noncontrolling interest in subsidiary -
Payment of contingent consideration -
Dividends paid -2603000
Derivative settlements -25000
Proceeds from exercise of stock options 210000
Excess tax benefits from stock based compensation -
Payments for taxes related to net share settlement of equity a -112000
Repurchase of common stock -
Other cash flows from financing activities -
Net cash flows from financing activities -7850000
Effect of exchange rate changes on cash, cash equivalents & r -
Net increase (decrease) in cash, cash equivalents & restricted 1659000
Cash, cash equivalents & restricted cash at the beginning of th 4295000
Cash, cash equivalents & restricted cash at the end of the peri 5954000
Effect of exchange rate changes on cash and cash equivalents -
Net increase (decrease) in cash & cash equivalents -
Cash & cash equivalents at the beginning of the year -
Cash & cash equivalents at the end of the year -
Net income 6631000
Depreciation & amortization 4371000
Goodwill impairments -
Losses on settlements of defined benefit pension plans -
Stock-based compensation 453000
Loss on early extinguishment of debt 79000
Deferred income taxes -654000
Other noncash items 264000
Loss (gain) on sale of subsidiary 205000
Deferred income taxes & other noncash items -
Accounts receivable, net -2158000
Inventories -1075000
Other current assets -
Other assets -614000
Accounts payable & pharmacy claims & discounts payable 3550000
Accounts payable & claims & discounts payable -
Health care costs payable & other insurance liabilities 320000
Accrued expenses -
Other long-term liabilities 1476000
Net cash flows from operating activities -
Profitability Ratios
1 Gross profit margin 0.1959718161
2 operating profit margin 0.0206651283
3 return on assets -0.004074256
4 return on common equity -0.006878901
5 earnings per share -0.568965517
6 price earnings ratio -115.1563636
7 payout ratio -3.430976431
Liquidity Ratios
8 current ratio 1.0280397191
9 quick ratio 0.6542525393
10 days cash on hand 13
11 days in acc payable 21.813520941
12 days in accrued liabilities 16.587600626
Activity Ratios
13 total asset turnover 1.3346205421
14 receivables turnover 12.63007919
15 inventory turnover 9.8561708562
16 fixed asset turnover 17.982440737
17 age of plant 5.7100809419
Coverage Ratios
18 debt to total assets 0.3478721617
19 debt to equity 1.0540015379
20 times interest earned 1.535318824
21 financial leverage index 1.6883823001
22 book value per share 82.71169
12/31/2018 12/31/2017 12/31/2016 12/31/2015
USD USD USD USD
Not Available Not Qualified Not Qualified Not Qualified